AFT Pharmaceuticals

AFT Pharmaceuticals Limited (AFP) is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties.

AFT's products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.

Its featured brand includes Crystaderm, coco-scalp and maxigesic.

Contact Details

Level 1, 129 Hurstmere Road , AUCKLAND New Zealand 0622

+64 9 488 0232

investor.relations@aftpharm.com

www.aftpharm.com

Lists and Charts

Share price

AFT Pharmaceuticals
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
977^th	Noxopharm	-10.01%	-19.18%
978^th	Little Green Pharma	-10.15%	0%
979^th	AFT Pharmaceuticals	-10.18%	-1.16%
980^th	Chalice Mining	-10.2%	51.68%
981^st	AIC Resources	-10.25%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEW ROLE: Andrew Lane, Non-Executive Director	03 Jul 2024
	NEW ROLE: Ted Witek, Non-Executive Director	17 Jan 2021
	NEW ROLE: Anita Baldauf, Non-Executive Director	13 Nov 2020
	NEW ROLE: Jon Lamb, Non-Executive Director	03 Nov 2020
	NEW ROLE: David Flacks, Non-Executive Chair	03 Nov 2020
	NEW ROLE: Doug Wilson, Non-Executive Director	03 Nov 2020
	NEW ROLE: Marree Atkinson, Chief of Staff, Managing Director	03 Nov 2020
	NEW ROLE: Hartley Atkinson, Founder, Chief Executive Officer, Executive Director	03 Nov 2020
	NEW ROLE: Jim Burns, Non-Executive Director	03 Nov 2020

Related Information

Access to our data for AFT Pharmaceuticals is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

AFT Pharmaceuticals is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today